Nazneen Aziz
Nessuna posizione attualmente
Profilo
Nazneen Aziz is the founder of Vitrimark, Inc. which was founded in 2004.
She held the titles of President, Secretary, Treasurer & Director.
Dr. Aziz's former jobs include Director-Translational Research at Novartis Institutes for Biomedical Research, Inc., Vice President-External Research at Point Therapeutics, Inc., Vice President-Research & Development at Interleukin Genetics, Inc., Group Leader-Gene Expression Division at Zycos, Inc., Chief Research Officer & Senior VP-Research at Phoenix Children's Hospital, and Assistant Professor at Harvard Medical School.
Dr. Aziz's education includes a graduate and doctorate degree from Massachusetts Institute of Technology and an undergraduate degree from Wellesley College.
Precedenti posizioni note di Nazneen Aziz
| Società | Posizione | Fine |
|---|---|---|
| Harvard Medical School | Corporate Officer/Principal | - |
Phoenix Children's Hospital
 Phoenix Children's Hospital Hospital/Nursing ManagementHealth Services Phoenix Children's Hospital provides health care services. Its pediatric specialty includes adolescent medicine, allergy and immunology, anesthesiology, bone marrow transplantation, critical care, dermatology, developmental pediatrics and emergency medicine. The company was founded in 1983 and is headquartered in Phoenix, AZ. | Direttore Tecnico/Scientifico/R&S | - |
Zycos, Inc.
 Zycos, Inc. Pharmaceuticals: MajorHealth Technology Zycos Inc. used to develop and market anticancer pharmaceutical and medical therapies and products. The company used to focus on drug discovery before redirecting toward drug development. Its core technology used to provide a direct method for the treatment of chronic viral infections and cancer as well as single product that work on all autoimmune diseases. Zycos was founded in 1996 and located in Lexington, MA | Corporate Officer/Principal | - |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Point Therapeutics, Inc.
 Point Therapeutics, Inc. BiotechnologyHealth Technology Point Therapeutics, Inc. develops drugs for the treatment of cancer and blood cell disorders. The company's PT-100 (talabostat) treats anemia and neutropenia (low levels of white blood cells), which can be caused by diseases or medical treatments, such as chemotherapy. The drugs stimulate production of proteins that build up the body's immune system against malignant tumors. Point Therapeutics, Inc. is located in Boston, MA. | Corporate Officer/Principal | - |
Formazione di Nazneen Aziz
| Massachusetts Institute of Technology | Doctorate Degree |
| Wellesley College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 6 |
|---|---|
Interleukin Genetics, Inc.
 Interleukin Genetics, Inc. Pharmaceuticals: MajorHealth Technology Interleukin Genetics, Inc. engages in the marketing and development of proprietary genetic tests for chronic inflammatory diseases and health-related conditions focuses on metabolism and inflammation. The company was founded in 1986 and is headquartered in Waltham, MA. | Health Technology |
Vitrimark, Inc.
 Vitrimark, Inc. Drugstore ChainsRetail Trade Vitrimark, Inc. develops new biomarkers for drug development. The company was founded by Arijit Bose and Nazneen Aziz in 2004 and is headquartered in Lexington, MA. | Retail Trade |
Point Therapeutics, Inc.
Point Therapeutics, Inc. BiotechnologyHealth Technology Point Therapeutics, Inc. develops drugs for the treatment of cancer and blood cell disorders. The company's PT-100 (talabostat) treats anemia and neutropenia (low levels of white blood cells), which can be caused by diseases or medical treatments, such as chemotherapy. The drugs stimulate production of proteins that build up the body's immune system against malignant tumors. Point Therapeutics, Inc. is located in Boston, MA. | Health Technology |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Commercial Services |
Zycos, Inc.
Zycos, Inc. Pharmaceuticals: MajorHealth Technology Zycos Inc. used to develop and market anticancer pharmaceutical and medical therapies and products. The company used to focus on drug discovery before redirecting toward drug development. Its core technology used to provide a direct method for the treatment of chronic viral infections and cancer as well as single product that work on all autoimmune diseases. Zycos was founded in 1996 and located in Lexington, MA | Health Technology |
Phoenix Children's Hospital
Phoenix Children's Hospital Hospital/Nursing ManagementHealth Services Phoenix Children's Hospital provides health care services. Its pediatric specialty includes adolescent medicine, allergy and immunology, anesthesiology, bone marrow transplantation, critical care, dermatology, developmental pediatrics and emergency medicine. The company was founded in 1983 and is headquartered in Phoenix, AZ. | Health Services |
- Borsa valori
- Insiders
- Nazneen Aziz
